Live Breaking News & Updates on Oncology Company Profile|Page 6
Stay updated with breaking news from Oncology company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Rating) have received a consensus recommendation of “Buy” from the seven research firms that are presently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokerages that have issued ratings on the […] ....
ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Rating) – Analysts at Lifesci Capital issued their FY2023 earnings per share (EPS) estimates for shares of ALX Oncology in a note issued to investors on Wednesday, April 26th. Lifesci Capital analyst S. Slutsky expects that the company will post earnings of ($4.17) per share for the year. […] ....
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Rating) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 479,800 shares, a growth of 37.9% from the May 15th total of 347,900 shares. Approximately 2.2% of the company’s shares are short sold. Based […] ....
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....
Equities research analysts expect that Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Rating) will announce earnings per share of ($0.68) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Pyxis Oncology’s earnings. The highest EPS estimate is ($0.51) and the lowest is ($0.84). The business is scheduled to issue its […] ....